Literature DB >> 16985479

Quality-of-life assessment of Ménière's disease patients after surgical labyrinthectomy.

Rodney C Diaz1, Michael J LaRouere, Dennis I Bojrab, John J Zappia, Eric W Sargent, Wayne T Shaia.   

Abstract

OBJECTIVE: To examine the impact of surgical labyrinthectomy on quality of life of Ménière's disease patients. STUDY
DESIGN: Cross-sectional survey.
SETTING: Otology subspecialty referral center. PATIENTS: All patients with Ménière's disease who underwent surgical labyrinthectomy between 1998 and 2004 were selected. Fifty-three patients satisfied inclusion criteria. Completed questionnaires were obtained from 44 patients. INTERVENTION(S): The Ménière's Disease Outcomes Questionnaire is a disease-specific quality-of-life questionnaire. It was used to assess the quality of life of patients before and after surgical labyrinthectomy. The questionnaire encompasses physical, mental, and social well-being domains of quality of life. MAIN OUTCOME MEASURE(S): Change in total quality-of-life score was used to assess the overall impact of surgical labyrinthectomy on subjective patient outcome. Individual quality-of-life domains were also assessed.
RESULTS: Forty-three of 44 respondents (98%) had improvement in total score after surgery. The one patient who demonstrated deterioration developed latent contralateral disease. Average preoperative and postoperative scores were 34 +/- 14 and 67 +/- 15, respectively (p < 0.001). All questions showed significant improvement with surgery (p < 0.001) except questions pertaining to memory (no change) and hearing loss (nonsignificant decrease in score).
CONCLUSION: This study comprises the first patient-directed assessment of quality-of-life outcomes in Ménière's disease patients after labyrinthectomy. Despite the disadvantage of hearing loss, patients consistently reported significant improvement in all quality-of-life domains and do not report a significant loss of quality of life in terms of their hearing loss. Surgical labyrinthectomy remains a highly effective treatment for Ménière's disease patients.

Entities:  

Mesh:

Year:  2007        PMID: 16985479     DOI: 10.1097/01.mao.0000233815.71671.6c

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  7 in total

1.  Vestibulo-ocular reflex responses to a multichannel vestibular prosthesis incorporating a 3D coordinate transformation for correction of misalignment.

Authors:  Gene Y Fridman; Natan S Davidovics; Chenkai Dai; Americo A Migliaccio; Charles C Della Santina
Journal:  J Assoc Res Otolaryngol       Date:  2010-02-23

2.  Treatment of Menière's Disease.

Authors:  Jeffrey D Sharon; Carolina Trevino; Michael C Schubert; John P Carey
Journal:  Curr Treat Options Neurol       Date:  2015-04       Impact factor: 3.598

3.  The Reliability and Validity of "Dokuz Eylül University Meniere's Disease Disability Scale".

Authors:  Başak Mutlu; Günay Kırkım; Serpil Mungan Durankaya; Selhan Gürkan; Tahsin Oğuz Başokçu; Enis Alpin Güneri
Journal:  J Int Adv Otol       Date:  2018-08       Impact factor: 1.017

4.  Patient Perceptions of Effectiveness in Treatments for Menière's Disease: a National Survey in Italy.

Authors:  Bryan Ward; Vincent Wettstein; John Golding; Giulia Corallo; Daniele Nuti; Franco Trabalzini; Marco Mandala
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

5.  Outcomes after cochlear implantation for patients with single-sided deafness, including those with recalcitrant Ménière's disease.

Authors:  Marlan R Hansen; Bruce J Gantz; Camille Dunn
Journal:  Otol Neurotol       Date:  2013-12       Impact factor: 2.311

6.  Labyrinthectomy and Vestibular Neurectomy for Intractable Vertiginous Symptoms.

Authors:  Alfredo Vega Alarcón; Lourdes Olivia Vales Hidalgo; Rodrigo Jácome Arévalo; Marite Palma Diaz
Journal:  Int Arch Otorhinolaryngol       Date:  2017-04

7.  Impact evaluation and association with EuroQol 5D health-related utility values in Ménière's disease.

Authors:  Ilmari Pyykkő; Vinaya Manchaiah; Hilla Levo; Erna Kentala
Journal:  Springerplus       Date:  2015-11-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.